TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
Lung cancer is the leading cause of cancer-related death and lung adenocarcinoma is its most common subtype. Although genetic alterations have been identified as drivers in subsets of lung adenocarcinoma, they do not fully explain tumor development. Epigenetic alterations have been implicated in the...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-09-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1009023 |
| _version_ | 1811180237766000640 |
|---|---|
| author | Daniel J Mullen Chunli Yan Diane S Kang Beiyun Zhou Zea Borok Crystal N Marconett Peggy J Farnham Ite A Offringa Suhn Kyong Rhie |
| author_facet | Daniel J Mullen Chunli Yan Diane S Kang Beiyun Zhou Zea Borok Crystal N Marconett Peggy J Farnham Ite A Offringa Suhn Kyong Rhie |
| author_sort | Daniel J Mullen |
| collection | DOAJ |
| description | Lung cancer is the leading cause of cancer-related death and lung adenocarcinoma is its most common subtype. Although genetic alterations have been identified as drivers in subsets of lung adenocarcinoma, they do not fully explain tumor development. Epigenetic alterations have been implicated in the pathogenesis of tumors. To identify epigenetic alterations driving lung adenocarcinoma, we used an improved version of the Tracing Enhancer Networks using Epigenetic Traits method (TENET 2.0) in primary normal lung and lung adenocarcinoma cells. We found over 32,000 enhancers that appear differentially activated between normal lung and lung adenocarcinoma. Among the identified transcriptional regulators inactivated in lung adenocarcinoma vs. normal lung, NKX2-1 was linked to a large number of silenced enhancers. Among the activated transcriptional regulators identified, CENPA, FOXM1, and MYBL2 were linked to numerous cancer-specific enhancers. High expression of CENPA, FOXM1, and MYBL2 is particularly observed in a subgroup of lung adenocarcinomas and is associated with poor patient survival. Notably, CENPA, FOXM1, and MYBL2 are also key regulators of cancer-specific enhancers in breast adenocarcinoma of the basal subtype, but they are associated with distinct sets of activated enhancers. We identified individual lung adenocarcinoma enhancers linked to CENPA, FOXM1, or MYBL2 that were associated with poor patient survival. Knockdown experiments of FOXM1 and MYBL2 suggest that these factors regulate genes involved in controlling cell cycle progression and cell division. For example, we found that expression of TK1, a potential target gene of a MYBL2-linked enhancer, is associated with poor patient survival. Identification and characterization of key transcriptional regulators and associated enhancers in lung adenocarcinoma provides important insights into the deregulation of lung adenocarcinoma epigenomes, highlighting novel potential targets for clinical intervention. |
| first_indexed | 2024-04-11T06:47:01Z |
| format | Article |
| id | doaj.art-692a71ce835c4814b88eb6d01cb57628 |
| institution | Directory Open Access Journal |
| issn | 1553-7390 1553-7404 |
| language | English |
| last_indexed | 2024-04-11T06:47:01Z |
| publishDate | 2020-09-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Genetics |
| spelling | doaj.art-692a71ce835c4814b88eb6d01cb576282022-12-22T04:39:19ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042020-09-01169e100902310.1371/journal.pgen.1009023TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.Daniel J MullenChunli YanDiane S KangBeiyun ZhouZea BorokCrystal N MarconettPeggy J FarnhamIte A OffringaSuhn Kyong RhieLung cancer is the leading cause of cancer-related death and lung adenocarcinoma is its most common subtype. Although genetic alterations have been identified as drivers in subsets of lung adenocarcinoma, they do not fully explain tumor development. Epigenetic alterations have been implicated in the pathogenesis of tumors. To identify epigenetic alterations driving lung adenocarcinoma, we used an improved version of the Tracing Enhancer Networks using Epigenetic Traits method (TENET 2.0) in primary normal lung and lung adenocarcinoma cells. We found over 32,000 enhancers that appear differentially activated between normal lung and lung adenocarcinoma. Among the identified transcriptional regulators inactivated in lung adenocarcinoma vs. normal lung, NKX2-1 was linked to a large number of silenced enhancers. Among the activated transcriptional regulators identified, CENPA, FOXM1, and MYBL2 were linked to numerous cancer-specific enhancers. High expression of CENPA, FOXM1, and MYBL2 is particularly observed in a subgroup of lung adenocarcinomas and is associated with poor patient survival. Notably, CENPA, FOXM1, and MYBL2 are also key regulators of cancer-specific enhancers in breast adenocarcinoma of the basal subtype, but they are associated with distinct sets of activated enhancers. We identified individual lung adenocarcinoma enhancers linked to CENPA, FOXM1, or MYBL2 that were associated with poor patient survival. Knockdown experiments of FOXM1 and MYBL2 suggest that these factors regulate genes involved in controlling cell cycle progression and cell division. For example, we found that expression of TK1, a potential target gene of a MYBL2-linked enhancer, is associated with poor patient survival. Identification and characterization of key transcriptional regulators and associated enhancers in lung adenocarcinoma provides important insights into the deregulation of lung adenocarcinoma epigenomes, highlighting novel potential targets for clinical intervention.https://doi.org/10.1371/journal.pgen.1009023 |
| spellingShingle | Daniel J Mullen Chunli Yan Diane S Kang Beiyun Zhou Zea Borok Crystal N Marconett Peggy J Farnham Ite A Offringa Suhn Kyong Rhie TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. PLoS Genetics |
| title | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. |
| title_full | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. |
| title_fullStr | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. |
| title_full_unstemmed | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. |
| title_short | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. |
| title_sort | tenet 2 0 identification of key transcriptional regulators and enhancers in lung adenocarcinoma |
| url | https://doi.org/10.1371/journal.pgen.1009023 |
| work_keys_str_mv | AT danieljmullen tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT chunliyan tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT dianeskang tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT beiyunzhou tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT zeaborok tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT crystalnmarconett tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT peggyjfarnham tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT iteaoffringa tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma AT suhnkyongrhie tenet20identificationofkeytranscriptionalregulatorsandenhancersinlungadenocarcinoma |